Deliberations resume in trial of ‘Pharma Bro’ Martin Shkreli
Jurors are deliberating for a second day at the federal securities fraud trial of former pharmaceutical company CEO Martin Shkreli.
They got the case Monday in New York and resumed work Tuesday.
Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.